[go: up one dir, main page]

ES556352A0 - Un procedimiento para preparar derivados de 5-oxo-1-imidazolidinacetamida - Google Patents

Un procedimiento para preparar derivados de 5-oxo-1-imidazolidinacetamida

Info

Publication number
ES556352A0
ES556352A0 ES556352A ES556352A ES556352A0 ES 556352 A0 ES556352 A0 ES 556352A0 ES 556352 A ES556352 A ES 556352A ES 556352 A ES556352 A ES 556352A ES 556352 A0 ES556352 A0 ES 556352A0
Authority
ES
Spain
Prior art keywords
branched
straight
alkyl
phenyl
imidazolidinacetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES556352A
Other languages
English (en)
Other versions
ES8800165A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISF SpA
Original Assignee
ISF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISF SpA filed Critical ISF SpA
Publication of ES8800165A1 publication Critical patent/ES8800165A1/es
Publication of ES556352A0 publication Critical patent/ES556352A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES556352A 1985-06-21 1986-06-20 Un procedimiento para preparar derivados de 5-oxo-1-imidazolidinacetamida Expired ES8800165A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8521235A IT1209644B (it) 1985-06-21 1985-06-21 Composti farmacologicamente attivi.

Publications (2)

Publication Number Publication Date
ES8800165A1 ES8800165A1 (es) 1987-11-01
ES556352A0 true ES556352A0 (es) 1987-11-01

Family

ID=11178813

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556352A Expired ES8800165A1 (es) 1985-06-21 1986-06-20 Un procedimiento para preparar derivados de 5-oxo-1-imidazolidinacetamida

Country Status (19)

Country Link
US (1) US4719222A (es)
EP (1) EP0206729B1 (es)
JP (1) JPH0696558B2 (es)
KR (1) KR870000304A (es)
AT (1) ATE60787T1 (es)
AU (1) AU586259B2 (es)
CA (1) CA1271598A (es)
DE (1) DE3677418D1 (es)
DK (1) DK290486A (es)
ES (1) ES8800165A1 (es)
FI (1) FI862421A (es)
GR (1) GR861579B (es)
HU (1) HUT41740A (es)
IL (1) IL79137A (es)
IT (1) IT1209644B (es)
NO (1) NO168173C (es)
PH (1) PH22131A (es)
PT (1) PT82814B (es)
ZA (1) ZA864447B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1222367B (it) * 1985-06-21 1990-09-05 Isf Spa Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
FR2677984B1 (fr) * 1991-06-21 1994-02-25 Elf Sanofi Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
CA2225325A1 (en) * 1997-12-19 1999-06-19 The University Of British Columbia Hemiasterlin analogs
WO2008132139A2 (en) * 2007-04-27 2008-11-06 Ucb Pharma S.A. New heterocyclic derivatives useful for the treatment of cns disorders
EP3096666B1 (en) 2014-01-22 2021-06-16 Helen of Troy Limited Mop with removable secondary cleaning head
JP2023552118A (ja) 2021-05-26 2023-12-14 ザ プロクター アンド ギャンブル カンパニー 複素環部分を有するプロ有益剤化合物
EP4450489A1 (en) * 2023-04-18 2024-10-23 Synaffix B.V. Stable 4-isoxazoline conjugates
WO2024218162A1 (en) * 2023-04-17 2024-10-24 Synaffix B.V. Cleavable immune cell engagers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH470396A (de) * 1963-08-12 1969-03-31 Hoffmann La Roche Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
IT1222367B (it) * 1985-06-21 1990-09-05 Isf Spa Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici

Also Published As

Publication number Publication date
ATE60787T1 (de) 1991-02-15
PH22131A (en) 1988-06-01
PT82814B (pt) 1988-04-21
JPS6230762A (ja) 1987-02-09
IT1209644B (it) 1989-08-30
FI862421A0 (fi) 1986-06-06
AU586259B2 (en) 1989-07-06
US4719222A (en) 1988-01-12
ZA864447B (en) 1987-02-25
FI862421A (fi) 1986-12-22
DK290486A (da) 1987-02-23
AU5891886A (en) 1986-12-24
KR870000304A (ko) 1987-02-17
EP0206729A3 (en) 1989-01-11
EP0206729A2 (en) 1986-12-30
CA1271598A (en) 1990-07-10
ES8800165A1 (es) 1987-11-01
IT8521235A0 (it) 1985-06-21
DK290486D0 (da) 1986-06-20
GR861579B (en) 1986-10-21
NO168173C (no) 1992-01-22
NO862485D0 (no) 1986-06-20
DE3677418D1 (de) 1991-03-14
PT82814A (en) 1986-07-01
HUT41740A (en) 1987-05-28
IL79137A (en) 1991-07-18
NO862485L (no) 1986-12-22
NO168173B (no) 1991-10-14
EP0206729B1 (en) 1991-02-06
JPH0696558B2 (ja) 1994-11-30

Similar Documents

Publication Publication Date Title
FI854821A0 (fi) Nya sura indolfoereningar och deras anvaendning som antiallergiska medel.
PT80117B (pt) Processo para a preparacao de 2-oxindole-1-carboxamidas 3-substituidas uteis como agentes analgesicos e anti-inflamatorios
ES520987A0 (es) Procedimiento para la preparacion de derivados de acido espiro (4.(3+n))-2-aza-3carboxilico.
ES556352A0 (es) Un procedimiento para preparar derivados de 5-oxo-1-imidazolidinacetamida
ES556351A0 (es) Un procedimiento para preparar derivados de pirrolidona
HUT41741A (en) Process for preparing new imidazolidinones and pharmaceutical compositions containing the new compounds

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506